Abstract
A recent working group meeting focused on contemporary cardiac issues in Duchenne muscular dystrophy (DMD) was hosted by the National Heart, Lung, and Blood Institute in collaboration with the Parent Project Muscular Dystrophy. An outcome of this meeting was to provide freely available detailed protocols for preclinical animal studies. The goal of these protocols is to improve the quality and reproducibility of cardiac preclinical studies aimed at developing new therapeutics for the prevention and treatment of DMD cardiomyopathy.
Original language | English (US) |
---|---|
Pages (from-to) | 85-86 |
Number of pages | 2 |
Journal | Journal of cardiovascular translational research |
Volume | 9 |
Issue number | 1 |
DOIs | |
State | Published - Feb 1 2016 |
Keywords
- Cardiology
- Cardiomyopathy
- Duchenne
- Preclinical
- Standard operating procedures (SOPs)
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Pharmaceutical Science
- Cardiology and Cardiovascular Medicine
- Genetics(clinical)